piracetam effect in 55 vertigo patients

Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes

Ordosgoitia H, Castro C, Carbayeda M, Labella T.

An Otorrinolaringol Ibero Am 1989;16(3):271-9

Abstract

We report on the therapeutic effect of a combination of piracetam and dihydroergocristine in 55 vertiginous patients, of both sexes, between 20 and 67 years of age, from different causes (not scheduled for surgery). The trial lasted 3 months, and the drugs were taken twice daily. Aside from one case who stopped the drug therapy because of intolerance, the conclusions drawn by the AA. are seemingly good, both subjectively and objectively (audiometric and electronystagmographic tracings).